Pharmaceutical Authentication via Molecular Computational Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The pharmaceutical industry faces significant challenges in authenticating pharmaceutical products due to the prevalence of counterfeit drugs, which can contain harmful ingredients and are difficult to distinguish from genuine products using existing tracking technologies like RFID tags, as these only verify the product's journey through the supply chain without ensuring product authenticity.
Innovation Solution
The use of Molecular Computational Identification (MCID) technology, which involves imbuing pharmaceutical molecules with fluorescent dyes to emit unique photonic signals for authentication, allowing for the creation of a predefined list to match the frequency and amplitude of signals with authentic products, thereby identifying counterfeit products.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If RFID tags are used to track pharmaceutical products through the supply chain, then product tracking capability is improved, but product authentication capability deteriorates because RFID tags cannot verify the authenticity of the pharmaceutical product itself
Solution Approach 1:
The patent introduces molecular computational identification (MCID) as an intermediary authentication mechanism that works alongside RFID tracking. MCID uses photonic signals from fluorescent dyes embedded in the pharmaceutical product to verify authenticity, while RFID continues to track supply chain movement. This mediator approach allows both tracking and authentication functions to operate simultaneously without compromising either capability.
Solution Approach 2:
The patent replaces the mechanical/electronic RFID authentication approach with a photonic-based molecular identification system. Instead of relying on electronic tags that can be replicated or removed, the system uses photonic signals emitted by fluorescent dyes at the molecular level, which are inherently tied to the pharmaceutical product's chemical composition and cannot be easily replicated by counterfeiters.
2Measurement precision
If photonic signal authentication is implemented, then product authentication accuracy is improved, but device complexity increases due to the need for photonic signal detection and matching systems
Solution Approach 1:
The patent implements preliminary action by pre-registering the photonic signal characteristics (frequency, amplitude, temporal patterns) of authentic pharmaceutical products in a database during manufacturing. This pre-characterization allows field authentication devices to simply compare detected signals against the stored reference profiles, significantly simplifying the complexity of field detection devices while maintaining high authentication accuracy.
Solution Approach 2:
The patent uses copying by creating digital replicas of the photonic signal characteristics from authentic products and storing them in a database. Field authentication devices then compare detected photonic signals against these copied reference profiles, eliminating the need for complex real-time analysis algorithms and reducing device complexity while maintaining measurement precision.
3Loss of information
If fluorescent dyes are embedded in pharmaceutical molecules, then product identification capability is improved, but manufacturing process complexity increases
Solution Approach 1:
The patent applies preliminary action by incorporating fluorescent dyes into the pharmaceutical manufacturing process itself, rather than as a separate post-processing step. The dyes are mixed with the active pharmaceutical ingredient during tablet compression or capsule filling, integrating the authentication feature into the existing manufacturing workflow and minimizing additional process complexity.
Solution Approach 2:
The patent uses parameter changes by selecting fluorescent dyes with specific excitation and emission wavelength characteristics that are optimized for detection with portable authentication devices. By carefully choosing dyes with distinct photonic signatures and appropriate stability parameters, the system achieves high identification capability while maintaining compatibility with standard pharmaceutical manufacturing processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively differentiates authentic from counterfeit pharmaceuticals by matching the photonic signals emitted by the products with pre-defined data, providing assurance of product integrity and reducing the risk of counterfeit sales at various stages, including point of sale.
Implementation Method 1
The use of Molecular Computational Identification (MCID) technology, which involves imbuing pharmaceutical molecules with fluorescent dyes to emit unique photonic signals for authentication
Data Source
AI summary
A method, apparatus and computer program product for authenticating a pharmaceutical product is provided. The method includes receiving an identifier and a quantity for the pharmaceutical product and receiving a photonic signal from the pharmaceutical product, wherein the photonic signal includes a frequency and amplitude. The method can further include searching for the identifier and quantity that was received in a predefined list comprising identifier-quantity pairs, wherein a frequency and amplitude corresponds to each identifier-quantity pair. The method can further include matching the identifier and quantity that was received to a first identifier-quantity pair in the list. The method can further include storing a record indicating that the pharmaceutical product is counterfeit if the frequency and amplitude of the photonic signal does not match the frequency and amplitude corresponding to the first identifier-quantity pair.